FDA Expands Indication for Spinal Muscular Atrophy Drug ...Middle East

Medscape - News
Originally approved for children with spinal muscular atrophy aged 2 months and older, risdiplam is now indicated for presymptomatic children younger than 2 months. FDA Approvals

Hence then, the article about fda expands indication for spinal muscular atrophy drug was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Indication for Spinal Muscular Atrophy Drug )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News